The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease
1 other identifier
observational
95
1 country
2
Brief Summary
Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes. Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2017
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedFirst Submitted
Initial submission to the registry
January 5, 2018
CompletedFirst Posted
Study publicly available on registry
January 10, 2018
CompletedJanuary 10, 2018
January 1, 2018
10 months
January 5, 2018
January 5, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
value of FVC/DLCO in predicting PAH in IPF
To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs
6 months
Interventions
forced vital capacity and diffusing capacity
Eligibility Criteria
\- ILD was diagnosed on the basis of clinical, radiological and functional assessments
You may qualify if:
- This retrospective study included all patients diagnosed with interstitial lung disease (ILD) who were followed up by the chest department of a tertiary hospital between September 2016 and January 2017
You may not qualify if:
- patients with occupational history
- collagen vascular disease predisposing them to lung disorders
- patients who could not undergo pulmonary function testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
AssiutU
Asyut, 71111, Egypt
Pulmonology Departments
Asyut, 71111, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pulmonology
Study Record Dates
First Submitted
January 5, 2018
First Posted
January 10, 2018
Study Start
February 2, 2017
Primary Completion
December 1, 2017
Study Completion
December 31, 2017
Last Updated
January 10, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share